Assessment of Activity in Sarcoidosis

Klech, H; Köhn, Horst; Kummer, F; Mostbeck, A

doi:10.1378/chest.82.6.732

Cited by 88 publications

(17 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On average, the sensitivity of the test to detect activity lays around 50%. Of note, the application of ACE insertion/deletion genotype correction may improve the test performance significantly [27][28][29][30][31][32]. Although elevated ACE cannot predict disease outcome, repeated measurement can nevertheless be useful for treatment monitoring [33,34].…”

Section: Fdg Pet/ct Compared To Conventional Markers Of Sarcoidosis Amentioning

confidence: 99%

In Which Patients with Sarcoidosis Is FDG PET/CT Indicated?

Keijsers

Grutters

2020

JCM

View full text Add to dashboard Cite

Sarcoidosis is a granulomatous disease of which the etiology remains unknown. The diverse clinical manifestations may challenge clinicians, particularly when conventional markers are inconclusive. From various studies, it has become clear that fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT aids in sarcoidosis care. In this article, an update on FDG PET/CT in sarcoidosis is provided. The use of FDG PET/CT in the diagnostic process of sarcoidosis is explained, especially in determining treatable inflammatory lesions in symptomatic patients with indecisive conventional tests. Furthermore, FDG PET/CT for evaluating the potential benefit of additional inflammatory treatment is described and its use in cardiac sarcoidosis is highlighted.

show abstract

Section: Fdg Pet/ct Compared To Conventional Markers Of Sarcoidosis Amentioning

confidence: 99%

In Which Patients with Sarcoidosis Is FDG PET/CT Indicated?

Keijsers

Grutters

2020

JCM

View full text Add to dashboard Cite

show abstract

“…Absorbable Gels and Gel-like Systems of Pharmaceutical Significance--Prior to outlining the key features of the drug carrier subject of the proposed studies, the physical and chemical properties of known gels and gel-like materials are discussed below. In addition, Klech (1992) and others (Miyata et al, 1979) have reviewed many other gel formers which are available for preparing pharmaceutical gels.…”

Section: A32mentioning

confidence: 99%

Injectable Absorbable Ocular Inserts for Controlled Drug Delivery

Shalaby¹

1997

View full text Add to dashboard Cite

“…46 67 Ga scanning shows pathologic uptake in lung lesions quite similar to sarcoidosis, 47 but never in parotid or lacrimal glands, as in sarcoidosis in about 20%. 48 Differential diagnosis to sarcoidosis is based on history of exposure, lack of erythema nodosum, uveitis, or bone cysts, a negative Kveim test, but a positive beryllium skin test, 1 a positive beryllium lymphocyte transfer test, 49 and lack of elevated SACE levels. 50 However, in recently exposed pa- tients ACE may be elevated.…”

Section: Chemicals Berylliosismentioning

confidence: 99%